4.7 Article

In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: Synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 44, 期 3, 页码 1296-1302

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2008.08.007

关键词

Platinum(II) complexes; Thiosemicarbazonato complexes; Crystal structure; In vitro and in vivo antitumor activity; Biological evaluation

向作者/读者索取更多资源

Reactions of thiosemicarbazones of 2-formyl and 2-acetyl pyridine and containing an azepane ring (hexamethyleneiminyl ring) incorporated at N(4)-position, HL1 (1) and HL2 (2) with platinum(II) afforded the complexes, [Pt(L-1)Cl] (3) and [Pt(L-2)Cl] (4). Characterization of the compounds was accomplished by means of elemental analysis and spectroscopic techniques NMR, UV-vis and IR spectroscopy. The single-crystal X-ray structure of complex [Pt(L-2)Cl] (4) shows that the ligand monoanion coordinates in a planar conformation to the metal via the pyridyl N atom, the imine-N atom, and thiolato S-atom. Compounds 1-4 have been evaluated for antiproliferative activity in vitro against three human cancer cell lines: MCF-7 (human breast cancer cell line), T24 (bladder cancer cell line), A-549 (non-small cell lung carcinoma) and a mouse L-929 (a fibroblast-like cell line cloned from strain L). Ligand 2 exhibited high activity as anticancer agent against all four cancer cell lines, while ligand 1 exhibited selectivity against MCF-7, L-929 cell lines and complex 4 against A-549, T-24 cancer cell lines. Also, the acute toxicity and antitumor activity were evaluated on leukemia P388-bearing mice. Complex 3 afforded five to six cures against leukemia P388. The in vivo results of the antitumor activity show the two platinum complexes as very effective chemotherapeutic antileukemic agents. (C) 2008 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Synthesis and anticancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3, 4-thiadiazole derivatives

Georgios Charitos, Dimitrios T. Trafalis, Panayiotis Dalezis, Constantinos Potamitis, Vasiliki Sarli, Panagiotis Zoumpoulakis, Charalambos Camoutsis

ARABIAN JOURNAL OF CHEMISTRY (2019)

Article Chemistry, Medicinal

Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy

T. Chatzisideri, S. Thysiadis, S. Katsamakas, P. Dalezis, I. Sigala, T. Lazarides, E. Nikolakaki, D. Trafalis, O. A. Gederaas, M. Lindgren, V. Sarli

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Novel c(RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy

Savvas Thysiadis, Sotirios Katsamakas, Panagiotis Dalezis, Theodora Chatzisieri, Dimitrios Trafalis, Vasiliki Sarli

FUTURE MEDICINAL CHEMISTRY (2017)

Article Oncology

Azasteroid Alkylators as Dual Inhibitors of AKT and ERK Signaling for the Treatment of Ovarian Carcinoma

Panagiotis Dalezis, Eleni Geromichalou, Aikaterini Polonifi, Sofia Sagredou, Nikolaos Nikoleousakos, Michael Nikolaou, Vasiliki Sarli, Mihalis I. Panayiotidis, Dimitrios T. Trafalis

CANCERS (2020)

Article Biotechnology & Applied Microbiology

3,6-Disubstituted 1,2,4-Triazolo[3,4-b] Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha

Sofia Sagredou, Panagiotis Dalezis, Nikolaos Nikoleousakos, Michail Nikolaou, Maria Voura, Konstantinos Almpanakis, Mihalis Panayiotidis, Vasiliki Sarli, Dimitrios T. Trafalis

ONCOTARGETS AND THERAPY (2020)

Article Biochemistry & Molecular Biology

Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA

Despoina Anastasiadou, Elena Geromichalou, Eleni Tsavea, George Psomas, Antonios G. Hatzidimitriou, Stavros Kalogiannis, George Geromichalos, Dimitrios Trafalis, Panagiotis Dalezis, Paraskevas Aslanidis

JOURNAL OF INORGANIC BIOCHEMISTRY (2020)

Article Chemistry, Medicinal

Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins

Theodora Chatzisideri, Panagiotis Dalezis, George Leonidis, Spyridon Bousis, Dimitrios Trafalis, Francesca Bianchini, Vasiliki Sarli

Summary: This study developed c(RGDyK)-CUCU conjugates for selective delivery of CUCUs to integrin-overexpressing cancer cells, showing activity against these cancer cells. The conjugates were approximately three times more active than free CUCU-D in MCF-7 cells.

FUTURE MEDICINAL CHEMISTRY (2021)

Article Pharmacology & Pharmacy

Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation

Dimitrios T. Trafalis, Sofia Sagredou, Panayiotis Dalezis, Maria Voura, Stella Fountoulaki, Nikolaos Nikoleousakos, Konstantinos Almpanakis, Maria V. Deligiorgi, Vasiliki Sarli

Summary: The fusion of 1,2,4-triazole and 1,3,4-thiadiazole rings resulted in compounds with potential anticancer properties, particularly KA25 and KA39 which exhibited inhibition of Akt phosphorylation. These compounds showed promise as cancer therapeutic agents due to their low acute toxicity and effective anticancer activity in vitro and in vivo.

PHARMACEUTICS (2021)

Article Pharmacology & Pharmacy

Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden

Sofia Sagredou, Panagiotis Dalezis, Eirini Papadopoulou, Maria Voura, Maria V. Deligiorgi, Michail Nikolaou, Mihalis I. Panayiotidis, George Nasioulas, Vasiliki Sarli, Dimitrios T. Trafalis

Summary: MSI, TMB, and PD-L1 are established as immunotherapy predictive biomarkers, with the compound KA39 showing potent anticancer activity through PD-L1 upregulation and MSI increase, particularly affecting MMR-deficient cells.

PHARMACEUTICS (2021)

Article Biochemistry & Molecular Biology

Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes in a Cell-Free Assay

Nikolaos Nikoleousakos, Panagiotis Dalezis, Aikaterini Polonifi, Elena G. Geromichalou, Sofia Sagredou, Constantinos E. Alifieris, Maria Deligiorgi, Vasiliki Sarli, Dimitrios T. Trafalis

Summary: Three newly synthesized B-lactam hybrid homo-aza-steroidal alkylators were evaluated for their PARP1/2 inhibition activity and DNA damaging effect against human ovarian carcinoma cells, with ASA-A and ASA-B showing the most significant anticancer activity.

BIOMEDICINES (2021)

Article Chemistry, Multidisciplinary

Synthesis and Biological Evaluation of a c(RGDyK) Peptide Conjugate of SRPIN803

George Leonidis, Panagiotis Dalezis, Dimitrios Trafalis, Dimitris Beis, Panagiota Giardoglou, Anastasia Koukiali, Ioanna Sigala, Eleni Nikolakaki, Vasiliki Sarli

Summary: The study successfully synthesized SRPIN803 and c(RGDyK)-SRPIN803 hybrid compounds, with one hybrid showing the highest activity and cytotoxicity against cancer cells, as well as antiangiogenic activity in zebrafish embryos. The hybrid compounds were found to be less potent than SRPIN803, but still showed interesting activities, demonstrating the potential of this approach for developing a new class of antiangiogenic compounds.

ACS OMEGA (2021)

Article Biochemistry & Molecular Biology

In silico study of potential antiviral activity of copper(II) complexes with non-steroidal anti-inflammatory drugs on various SARS-CoV-2 target proteins

Elena G. Geromichalou, Dimitrios T. Trafalis, Panagiotis Dalezis, Georgios Malis, George Psomas, George D. Geromichalos

Summary: This study investigated the interactions between non-steroidal anti-inflammatory drugs and copper complexes, as well as their potential as antiviral agents against SARS-CoV-2. Cytotoxic activity on human cell lines was also evaluated.

JOURNAL OF INORGANIC BIOCHEMISTRY (2022)

Article Chemistry, Inorganic & Nuclear

Silver(I) complexes bearing heterocyclic thioamide ligands with NH2 and CF3 substituents: effect of ligand group substitution on antibacterial and anticancer properties

Despoina Varna, Elena Geromichalou, Antonios G. Hatzidimitriou, Rigini Papi, George Psomas, Panagiotis Dalezis, Paraskevas Aslanidis, Theodora Choli-Papadopoulou, Dimitrios T. Trafalis, Panagiotis A. Angaridis

Summary: In recent years, there has been increasing interest in studying Ag(I) coordination compounds as effective antibacterial and anticancer agents. This study synthesized a series of Ag(I) complexes with phosphines and heterocyclic thioamide ligands, and evaluated their antibacterial and anticancer properties. The results showed that some of these complexes exhibited potent activity against bacteria and cancer cells, with certain selectivity towards normal cells.

DALTON TRANSACTIONS (2022)

Article Pharmacology & Pharmacy

8-Hydroxy-2'-Deoxyguanosine and 8-Nitroguanine Production and Detection in Blood Serum of Breast Cancer Patients in Response to Postoperative Complementary External Ionizing Irradiation of Normal Tissues

Kosmas E. Verigos, Sofia Sagredou, Kyriakos Orfanakos, Panayiotis Dalezis, Dimitrios T. Trafalis

DOSE-RESPONSE (2020)

Article Chemistry, Medicinal

Discovery of steroidal lactam conjugates of POPAM-NH2 with potent anticancer activity

Dimitrios Trafalis, Panagiotis Dalezis, Elena Geromichalou, Sofia Sagredou, Eleni Sflakidou, Maria Voura, Margarita Grammatikopoulou, Catherine Gabriel, Vasiliki Sarli

FUTURE MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)